The Warsaw-based medical devise maker announced on Tuesday that David C. Dvorak was stepping down immediately as president and chief executive officer, according to a news release from the company.
Zimmer Biomet Chief Financial Officer Daniel P. Florin was appointed as interim chief executive officer until a replacement can be found.
Dvorak will serve in an advisory capacity to advise with the transition for a period of time, the company said.
Dvorak had served as chief executive officer and president of Zimmer Biomet Holdings Inc. since May 1, 2007.
Zimmer Biomet Holdings Inc. shares declined slightly after the announcement was issued. The stock was trading at $127 per share early today.
In a separate statement, the company said it expects per-share earnings "to be at or near the bottom of its previously issued guidance range of $2.08 to $2.13," according to a report from Marketwatch.com.
